MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

BEDFORD, Mass., May 11 Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical ...

HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...

MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...

--Smaller 6mm Diameter and Other Product Enhancements are Designed to Increase Patient Comfort and Improve Physician Ease-of-Use-- MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ --Hologic, Inc ...

NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients The pivotal study ...

Recently, Conceptus (NasdaqGS:CPTS - News) received an Approvable Letter from the US Food and Drug Administration (:FDA). The letter suggests compatibility between the company’s surgical permanent ...

1. The NovaSure RF controller is a Class I, defibrillator-proof Type bf instrument, according to iec 60601-1. 2. The NovaSure RF controller is a Class III device by FDA regulation. 3. The NovaSure RF ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...

BEDFORD, Mass., Nov. 19, 2014 /PRNewswire/ -- Hologic, Inc. , today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The NovaSure system is designed ...